Combination dose finding trials for targeted/immuno oncology agents in early development: Lessons learned.
Year: 2022
Type: conference-abstract
Source: Journal of Clinical Oncology
Institution: Pfizer (United States)
Language: English
Subfield: Statistics and Probability
Field: Mathematics
Domain: Physical Sciences
Open Access status: closed
OpenAlex ID: W4286296020
